Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis

Neurobiology of Aging

Volumn 27, Issue 9, 2006, Pages 1250-1257

  Carro, E ^a   Trejo, J L ^a   Gerber, A ^b   Loetscher, H ^b   Torrado, J ^c   Metzger, F ^b   Torres Aleman, I ^a  

^a INSTITUTO CAJAL   (Spain)

^b Preclinical Research   (Switzerland)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Alzheimer's disease; Amyloidosis; Cognitive loss; Insulin like growth factor I; Presenilin; Therapy

Indexed keywords

ALBUMIN; AMYLOID BETA PROTEIN; BRAIN PROTEIN; CARRIER PROTEIN; CLUSTERIN; PREALBUMIN; SOMATOMEDIN C;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN DISEASE; BRAIN LEVEL; CHOROID PLEXUS; COGNITION; COGNITIVE DEFECT; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; SLOW RELEASE FORMULATION; STATISTICAL SIGNIFICANCE;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOIDOSIS; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BLOOD-BRAIN BARRIER; BRAIN CHEMISTRY; BRAIN DISEASES; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; SPATIAL BEHAVIOR;

EID: 33746215099     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2005.06.015     Document Type: Article

References (35)

1. Carrascosa C., Torres-Aleman I., Lopez-Lopez C., Carro E., Espejo L., Torrado S., et al. Microspheres containing insulin-like growth factor I for treatment of chronic neurodegeneration. Biomaterials 25 4 (2004) 707-714
2. Carro E.T.-A.I. Insulin-like growth factor I and Alzheimer's disease: therapeutic prospects?. Exp Rev Neurother 4 1 (2004) 79-86
3. Carro E., Trejo J.L., Busiguina S., and Torres-Aleman I. Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J Neurosci 21 15 (2001) 5678-5684
4. Carro E., Trejo J.L., Gomez-Isla T., LeRoith D., and Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med 8 12 (2002) 1390-1397
5. Davis J.N., and Chisholm J.C. The 'amyloid cascade hypothesis' of AD: decoy or real McCoy?. Trends Neurosci 20 12 (1997) 558-559
6. DeKosky S.T., and Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27 5 (1990) 457-464
7. Dodart J.C., Bales K.R., Gannon K.S., Greene S.J., DeMattos R.B., Mathis C., et al. Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat Neurosci 5 5 (2002) 452-457
8. Dubnau J., Grady L., Kitamoto T., and Tully T. Disruption of neurotransmission in Drosophila mushroom body blocks retrieval but not acquisition of memory. Nature 411 6836 (2001) 476-480
9. Fernandez A.M., de la Vega A.G., and Torres-Aleman I. Insulin-like growth factor I restores motor coordination in a rat model of cerebellar ataxia. Proc Natl Acad Sci USA 95 3 (1998) 1253-1258
10. Frisch C., Dere E., Silva M.A., Godecke A., Schrader J., and Huston J.P. Superior water maze performance and increase in fear-related behavior in the endothelial nitric oxide synthase-deficient mouse together with monoamine changes in cerebellum and ventral striatum. J Neurosci 20 17 (2000) 6694-6700
11. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 5580 (2002) 353-356
12. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274 5284 (1996) 99-102
13. Jankowsky J.L., Fadale D.J., Anderson J., Xu G.M., Gonzales V., Jenkins N.A., et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13 2 (2004) 159-170
14. Janus C., Phinney A.L., Chishti M.A., and Westaway D. New developments in animal models of Alzheimer's disease. Curr Neurol Neurosci Rep 1 5 (2001) 451-457
15. Kumar-Singh S., Dewachter I., Moechars D., Lubke U., De Jonghe C., Ceuterick C., et al. Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation. Neurobiol Dis 7 1 (2000) 9-22
16. Lue L.F., Kuo Y.M., Roher A.E., Brachova L., Shen Y., Sue L., et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155 3 (1999) 853-862
17. Masliah E., Mallory M., Alford M., DeTeresa R., Hansen L.A., McKeel Jr. D.W., et al. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology 56 1 (2001) 127-129
18. Mayeux R. Epidemiology of neurodegeneration. Annu Rev Neurosci 26 (2003) 81-104
19. McGraw J., Hiebert G.W., and Steeves J.D. Modulating astrogliosis after neurotrauma. J Neurosci Res 63 2 (2001) 109-115
20. McLean C.A., Cherny R.A., Fraser F.W., Fuller S.J., Smith M.J., Beyreuther K., et al. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46 6 (1999) 860-866
21. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Meth 11 1 (1984) 47-60
22. Mufson E.J., Counts S.E., and Ginsberg S.D. Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease. Neurochem Res 27 10 (2002) 1035-1048
23. Okamoto P.M., Gamby C., Wells D., Fallon J., and Vallee R.B. Dynamin isoform-specific interaction with the shank/ProSAP scaffolding proteins of the postsynaptic density and actin cytoskeleton. J Biol Chem 276 51 (2001) 48458-48465
24. Pons S., and Torres-Aleman I. Insulin-like growth factor-I stimulates dephosphorylation of Ikappa B through the serine phosphatase calcineurin (protein phosphatase 2B). J Biol Chem 275 49 (2000) 38620-38625
25. Richards J.G., Higgins G.A., Ouagazzal A.M., Ozmen L., Kew J.N., Bohrmann B., et al. PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation. J Neurosci 23 26 (2003) 8989-9003
26. Rostworowski M., Balasingam V., Chabot S., Owens T., and Yong V.W. Astrogliosis in the neonatal and adult murine brain post-trauma: elevation of inflammatory cytokines and the lack of requirement for endogenous interferon-gamma. J Neurosci 17 10 (1997) 3664-3674
27. Selkoe D.J. Clearing the Brain's Amyloid Cobwebs. Neuron 32 2 (2001) 177-180
28. Shibata M., Yamada S., Kumar S.R., Calero M., Bading J., Frangione B., et al. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106 12 (2000) 1489-1499
29. Strazielle N., and Ghersi-Egea J.F. Demonstration of a coupled metabolism-efflux process at the choroid plexus as a mechanism of brain protection toward xenobiotics. J Neurosci 19 15 (1999) 6275-6289
30. Suzuki N., Cheung T.T., Cai X.D., Odaka A., Otvos Jr. L., Eckman C., et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264 5163 (1994) 1336-1340
31. Trejo J.L., Carro E., Garcia-Galloway E., and Torres-Aleman I. Role of insulin-like growth factor I signaling in neurodegenerative diseases. J Mol Med 82 3 (2004) 156-162
32. von Kienlin M., Kunnecke B., Metzger F., Steiner G., Richards J.G., Ozmen L., et al. Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span. Neurobiol Dis 18 1 (2005) 32-39
33. Yao P.J. Synaptic frailty and clathrin-mediated synaptic vesicle trafficking in Alzheimer's disease. Trends Neurosci 27 1 (2004) 24-29
34. Yao P.J., Zhu M., Pyun E.I., Brooks A.I., Therianos S., Meyers V.E., et al. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol Dis 12 2 (2003) 97-109
35. Zlokovic B.V. Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier. Life Sci 59 18 (1996) 1483-1497